Education
About Us
Working with TipRanks
Follow Us
Microbix Biosystms J (TSE:MBX)
TSX:MBX
MBX Analyst Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MBX Stock 12 Month Forecast
Average Price Target
C$0.50
▲(108.33% Upside)
| Highest Price TargetC$0.50 | Average Price TargetC$0.50 | Lowest Price TargetC$0.50 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Bloom Burton
C$0.5
Buy
108.33%
Upside
Reiterated
12/19/25
We have adjusted our forecasts based on Microbix’s FY4Q-2025 financial results and have rolled forward our estimates for the new fiscal year. The net result is no change to our target price. We are maintaining our $0.50 TP and ACCUMULATE rating (Above Average Risk). Microbix is differentiated with highly specialized infrastructure. However, loss of the QuidelOrtho opportunity, and the plummet in Chinese antigen sales have left a big revenue gap, and we believe MBX will remain a “show me” story until several quarters of robust growth are reported. That said, we continue to believe that long term value exists, and encourage accumulating on MBX stock weakness. The company continues to repurchase shares under their renewed NCIB.
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bloom Burton
C$0.5
Buy
108.33%
Upside
Reiterated
12/19/25
We have adjusted our forecasts based on Microbix’s FY4Q-2025 financial results and have rolled forward our estimates for the new fiscal year. The net result is no change to our target price. We are maintaining our $0.50 TP and ACCUMULATE rating (Above Average Risk). Microbix is differentiated with highly specialized infrastructure. However, loss of the QuidelOrtho opportunity, and the plummet in Chinese antigen sales have left a big revenue gap, and we believe MBX will remain a “show me” story until several quarters of robust growth are reported. That said, we continue to believe that long term value exists, and encourage accumulating on MBX stock weakness. The company continues to repurchase shares under their renewed NCIB.
Best Analysts Covering Microbix Biosystms
3 Months
xxx
Success Rate
2/11 ratings generated profit
Average Return
-11.20%
reiterated a xxx
rating 29 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 18.18% of your transactions generating a profit, with an average return of -11.20% per trade.
1 Year
Success Rate
3/11 ratings generated profit
Average Return
-15.41%
reiterated a buy rating 29 days ago
Copying David Martin PhD's trades and holding each position for 1 Year would result in 27.27% of your transactions generating a profit, with an average return of -15.41% per trade.
2 Years
xxx
Success Rate
1/11 ratings generated profit
Average Return
-28.85%
reiterated a xxx
rating 29 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 9.09% of your transactions generating a profit, with an average return of -28.85% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MBX Analyst Recommendation Trends
Rating
Jun 25
Jul 25
Aug 25
Oct 25
Dec 25
Strong Buy
3
3
3
2
2
Buy
0
0
0
0
0
Hold
7
9
13
25
27
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
10
12
16
27
29
Each month's total comprises the sum of three months' worth of ratings.
MBX Financial Forecast
MBX Stock Forecast FAQ
What is TSE:MBX’s average 12-month price target, according to analysts?
Based on analyst ratings, Microbix Biosystms J’s 12-month average price target is 0.50.
What is TSE:MBX’s upside potential, based on the analysts’ average price target?
Microbix Biosystms J has 108.33% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TSE:MBX a Buy, Sell or Hold?
Microbix Biosystms J has a consensus rating of Moderate Buy which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Microbix Biosystms J’s price target?
The average price target for Microbix Biosystms J is 0.50. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is C$0.50 ,the lowest forecast is C$0.50. The average price target represents 108.33% Increase from the current price of C$0.24.
The highest analyst price target is C$0.50 ,the lowest forecast is C$0.50. The average price target represents 108.33% Increase from the current price of C$0.24.
What do analysts say about Microbix Biosystms J?
Microbix Biosystms J’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of TSE:MBX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.